Arcturus Therapeutics (ARCT) - Coronavirus stock
Apr 22, 2020 10:29:01 GMT
JHam and selluwud like this
Post by magnus123 on Apr 22, 2020 10:29:01 GMT
I found this company recently and i think that it is really worth a look. They are currently working on a Vaccine against Coronavirus. It's a relatively small and still unknown company. Arcturus raised appr. $80 Million Cash at $17/PPS recently, so they are well funded. The rally so far was nice, but i believe that there is great potential for further gains.
Market Cap at ~$359 Million.
arcturusrx.com/pipeline/#lunarcovid19
"The LUNAR-COVID19 Solution
Arcturus is combining its self-replicating mRNA STARR™ Technology with their LUNAR® RNA medicine delivery technology to developing a prophylactic vaccine against COVID-19. The combination of these two technologies results in (1) an mRNA vaccine that can be produced more rapidly than conventional adjuvanted protein based vaccine; (2) a significant reduction in the mRNA dose required to elicit a protective immune response; and (3) an increase in the duration of antigen expression potentially yielding protection from COVID-19 with a single dose."
The company is beside of the Corona play also interesting with a late stage candidate for ornithine transcarbamylase. A disease with no cure.
I will start with an initial position today.
Market Cap at ~$359 Million.
arcturusrx.com/pipeline/#lunarcovid19
"The LUNAR-COVID19 Solution
Arcturus is combining its self-replicating mRNA STARR™ Technology with their LUNAR® RNA medicine delivery technology to developing a prophylactic vaccine against COVID-19. The combination of these two technologies results in (1) an mRNA vaccine that can be produced more rapidly than conventional adjuvanted protein based vaccine; (2) a significant reduction in the mRNA dose required to elicit a protective immune response; and (3) an increase in the duration of antigen expression potentially yielding protection from COVID-19 with a single dose."
The company is beside of the Corona play also interesting with a late stage candidate for ornithine transcarbamylase. A disease with no cure.
I will start with an initial position today.
